PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K113. A total of 52 filers reported holding PHOENIX BIOTECH ACQUISITION in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6 | +20.0% | 89,687 | 0.0% | 0.00% | – |
Q2 2023 | $5 | +25.0% | 89,687 | +2.3% | 0.00% | – |
Q1 2023 | $4 | -73.3% | 87,656 | -75.3% | 0.00% | – |
Q4 2022 | $15 | -99.9% | 355,185 | +4.9% | 0.00% | -100.0% |
Q3 2022 | $27,000 | -18.2% | 338,718 | +1.7% | 0.00% | 0.0% |
Q2 2022 | $33,000 | +1550.0% | 333,118 | +5646.4% | 0.00% | – |
Q4 2021 | $2,000 | – | 5,797 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 163,538 | $1,746,586 | 0.12% |
Q Global Advisors, LLC | 170,785 | $7 | 0.01% |
Atalaya Capital Management LP | 225,000 | $9,000 | 0.00% |
MMCAP International Inc. SPC | 375,000 | $15,000 | 0.00% |
Segantii Capital Management Ltd | 5,000 | $53,400 | 0.00% |
DIFESA CAPITAL MANAGEMENT, LP | 62,500 | $2,506 | 0.00% |
PERISCOPE CAPITAL INC. | 957,098 | $38,301 | 0.00% |
Sage Rock Capital Management LP | 91,999 | $3,689 | 0.00% |
Castle Creek Arbitrage, LLC | 200,000 | $8,000 | 0.00% |
Context Capital Management, LLC | 200,000 | $8 | 0.00% |